Compugen to Present at JMP Securities Life Sciences Conference in New York
June 15 2015 - 7:00AM
Business Wire
Compugen Ltd. (NASDAQ: CGEN) today announced that Ari Krashin,
Chief Financial Officer of Compugen, will present a corporate
overview and update at the JMP Securities Life Sciences Conference
in New York on Wednesday, June 24 at 11:00 a.m. ET.
About Compugen
Compugen is a leading predictive drug discovery company focused
on monoclonal antibodies and therapeutic proteins to address
important unmet needs in the fields of oncology and
immunology. The Company utilizes a broad and continuously
growing integrated infrastructure of proprietary scientific
understandings and predictive platforms, algorithms, machine
learning systems and other computational biology capabilities for
the in silico (by computer) prediction and selection of
novel drug target candidates, which are then advanced in its
Pipeline Program. The discovery and development of monoclonal
antibody therapeutic candidates against selected
Compugen-discovered novel target candidates is performed by
Compugen’s wholly-owned US subsidiary located in South San
Francisco. The Company's business model includes collaborations
covering the further development and commercialization of product
candidates at various stages from its Pipeline Program and various
forms of research and discovery agreements, in both cases providing
Compugen with potential milestone payments and royalties on product
sales or other forms of revenue sharing. For additional
information, please visit Compugen's corporate website at
www.cgen.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150615005583/en/
Compugen Ltd.Tsipi Haitovsky, +972-52-598-9892Global Media
Liaisontsipih@cgen.com
Compugen (NASDAQ:CGEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Compugen (NASDAQ:CGEN)
Historical Stock Chart
From Apr 2023 to Apr 2024